Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.65 USD -0.93% Market Closed
Market Cap: 145.8B USD

Intrinsic Value

The intrinsic value of one PFE stock under the Base Case scenario is 28.4 USD. Compared to the current market price of 25.65 USD, Pfizer Inc is Undervalued by 10%.

PFE Intrinsic Value
28.4 USD
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pfizer Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about PFE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PFE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pfizer Inc.

Explain Valuation
Compare PFE to
Custom
Choose any stock to compare

Fundamental Analysis

PFE Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

PFE Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Pfizer’s revenue from its COVID-19 vaccine may sharply fall as the pandemic fades, creating reliance on a still-emerging pipeline that may struggle to offset the loss of high-margin vaccine income.

Patent expirations on blockbuster drugs like Ibrance and Xeljanz pose a significant threat to long-term sales growth, as cheaper generics or biosimilars could rapidly erode market share.

Amid rising scrutiny over drug pricing and intensifying regulatory efforts in major markets, Pfizer's historically premium-priced portfolio may face margin pressure and unpredictable pricing environments.

Bull Theses

A robust late-stage pipeline in immunology, oncology, and vaccine segments could yield multiple blockbuster approvals, helping Pfizer not only offset patent-cliff losses but also drive new revenue growth.

The company’s healthy balance sheet and solid cash flows enable strategic acquisitions of smaller biotech innovators, bolstering Pfizer’s R&D capabilities and strengthening its future product portfolio.

Pfizer’s successful collaboration with BioNTech on the COVID-19 vaccine highlights growing expertise in mRNA technology, positioning the firm to capitalize on novel treatments and next-generation vaccines beyond the pandemic.

Show More Less
How do you feel about PFE?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Pfizer Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

PFE Price Targets Summary
Pfizer Inc

Wall Street analysts forecast PFE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PFE is 29.42 USD with a low forecast of 23.23 USD and a high forecast of 39.42 USD.

Lowest
Price Target
23.23 USD
9% Downside
Average
Price Target
29.42 USD
15% Upside
Highest
Price Target
39.42 USD
54% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Jan 19, 2026
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for PFE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PFE Insider Trading
Buy and sell transactions by insiders

PFE News

Other Videos
What is the Intrinsic Value of one PFE stock?

The intrinsic value of one PFE stock under the Base Case scenario is 28.4 USD.

Is PFE stock undervalued or overvalued?

Compared to the current market price of 25.65 USD, Pfizer Inc is Undervalued by 10%.

Back to Top